Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CBPO Net Margin

The Net Margin of China Biologic Products Holdings Inc (CBPO) is 29.04%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

CBPO Net Margin - Historical Value
Date Value
2020-12-31 29.04%
2019-12-31 27.56%
2018-12-31 27.43%
2017-12-31 18.34%
2016-12-31 30.71%
2015-12-31 30.04%
2014-12-31 29.15%
2013-12-31 26.84%
2012-12-31 24.46%
2011-12-31 11.89%
CBPO Net Margin - Peers Comparison
Ticker Name Value
300122.SZ Chongqing Zhifei Biological Products Co Ltd -164.35%
300142.SZ Walvax Biotechnology Co Ltd 7.35%
ARWR Arrowhead Pharmaceuticals, Inc. -160.64%
BCRX BioCryst Pharmaceuticals, Inc. 30.16%
INSM Insmed Incorporated -210.54%
MYGN Myriad Genetics, Inc. -44.38%
ORGO Organogenesis Holdings Inc. 6.56%
6160.HK Beigene Ltd -517.01%
AMRN Amarin Corporation PLC -18.16%
CHRS Coherus Oncology Inc 398.43%
MDXG MiMedx Group, Inc. 11.60%
XNCR Xencor, Inc. -73.20%
300601.SZ Shenzhen Kangtai Biological Products Co Ltd 2.63%
688363.SS Bloomage Biotechnology Corp Ltd 6.96%
SRRK Scholar Rock Holding Corporation -405.21%
TWST Twist Bioscience Corporation -28.34%
1801.HK Innovent Biologics Inc 6.24%
603392.SS Beijing Wantai Biological Pharmacy Enterprise Co Ltd -21.90%
HRTX Heron Therapeutics Inc -13.04%
PGEN Precigen, Inc. -2588.21%
EXEL Exelixis Inc 33.73%
MORF Morphic Holding Inc -29192.90%
PTCT PTC Therapeutics, Inc. 39.44%
VCEL Vericel Corporation 5.98%
ZNTL Zentalis Pharmaceuticals, Inc. -245.96%
ACAD Acadia Pharmaceuticals Inc. 36.49%
TVTX Travere Therapeutics, Inc. -5.21%
VIR Vir Biotechnology, Inc. -638.87%
002007.SZ Hualan Biological Engineering Inc 20.47%
300896.SZ Imeik Technology Development Co Ltd 52.64%
9688.HK Zai Lab Ltd -38.15%
AGIO Agios Pharmaceuticals, Inc. -764.01%
EDIT Editas Medicine, Inc. -395.01%
MDGL Madrigal Pharmaceuticals, Inc. -30.08%
SRNE Sorrento Therapeutics Inc -912.10%
ENTA Enanta Pharmaceuticals Inc -125.36%
MGNX MacroGenics Inc -49.91%